Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms (LUTS) Post Ureteroscopy for Stone Management

NCT01381120 is registered in ClinicalTrials.gov with Barrie Urology Associates as lead sponsor.

NCT NCT01381120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01381120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms (LUTS) Post Ureteroscopy for Stone Management
Lead sponsor
Barrie Urology Associates
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2010
Completion date
June 30, 2012
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

flank pain, urinary bladder, overactive